C Signs
C the Signs is a London-based company focused on cancer detection. Established in 2017, it specializes in using advanced technology to identify patients at risk of cancer at early and treatable stages. The company offers a sophisticated cancer prediction system that utilizes Artificial Intelligence to analyze extensive data from patient electronic health records. This system provides personalized risk profiles by considering a variety of personal and environmental factors. The platform is designed for use by healthcare professionals across various settings, including primary care and urgent care. It supports cancer prevention, screening, and surveillance, and can integrate with existing clinical systems to enhance risk assessment. C the Signs has made significant contributions to the UK's National Health Service, helping to detect cancers earlier than traditional methods. With recent funding, the company plans to expand its services from the UK to the US, aiming to improve cancer survival rates globally.
Work at C Signs in HR or recruiting? Claim this page
Headcount trend
C Signs went from 19 employees in Jul 2023 to 18 in Jun 2025. Jan to Jun 2025: 3 people joined, 0 left.
Headcount data through Jun 2025
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Feb 2022 | Series A | $6.8M | 3 | |
| Oct 2018 | Funding | $100K | 1 |
Org structure
Headcount by department
Peer reviews
Worked with someone at C Signs?
Anonymous peer reviews on OffTheRecord
Similar companies
Hiring now
C Signs FAQ
How many employees does C Signs have?
C Signs has about 18 employees, unchanged over the 3 months to Jun 2025.
How much funding has C Signs raised?
C Signs has raised $6.91M in total funding; its latest round was Series A in Feb 2022.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.